Company Overview
Team Members
Technologies
Email Formats
Competitors
Faqs

10 free leads on us

Use our Chrome Extension & instantly connect with prospects

Download Free
Use Google
crystals

Find Contacts

Homepage  >  Fitness & Dance Facilities  > 

AtheroGenics

Company Name

AtheroGenics

Main Industry

Fitness & Dance Facilities, Hospitality

Website

www.atherogenics.com

Contact Information

Norcross, Georgia Office

3065 Northwoods Circle East Tower Ste 1140, Norcross, Georgia, 30071, United States

Alpharetta, Georgia Office

8995 Westside Pkwy, Alpharetta, Georgia, 30004, United States

(678) 336-2500

AtheroGenics Profile and History

AtheroGenics is a publicly traded, emerging pharmaceutical company focused on the discovery, development and commercialization of novel pharmaceutical products that address critical unmet needs in the treatment of chronic inflammatory diseases, including diabetes and atherosclerosis. The Company's lead compound, AGI-1067, is a novel orally available anti-oxidant with anti-inflammatory properties t hat was discovered by AtheroGenics scientists. AtheroGenics is studying AGI-1067 in a Phase III clinical trial called ANDES (AGI-1067 as a Novel Anti-Diabetic Agent Evaluation Study) to assess the ability of AGI-1067 to control blood sugar levels in patients with diabetes. Patient enrollment in ANDES was completed in December 2007. A pre-planned interim analysis to evaluate the efficacy and safety of AGI-1067 after three months of dosing will be conducted in the second quarter of 2008. The Company expects to release final data on the full six months of dosing during the second half of 2008. AtheroGenics was incorporated in Georgia in 1993 and is based in Alpharetta, Georgia. The Company currently has 70 employees, with a senior management team comprised of executives from leading pharmaceutical companies and academic institutions.

...Read More

Atherogenics

Atherogenics Inc

HEROgenics

Athero Genics Inc

Revenue

$13 M

Employees

70

Founded

1993

AtheroGenics Executive Team & Key Decision Makers

Name & TitleContact Info
Charles Kunsch
Charles Kunsch

Director, Biological Research

(678) ❅❅❅-❅❅❅❅

Visit Profile

Top AtheroGenics Integrations and Technologies

Here's a list of some of the top trending technologies and APIs used by AtheroGenics.

Other Web Tools and Plugins

(3 Technologies)

Web Content Management Systems

(2 Technologies)

Frameworks and Libraries

(2 Technologies)

Programming Languages

(2 Technologies)

Web Fonts

(1 Technologies)

AtheroGenics Email Formats

ParameterSample EmailPercentage

AtheroGenics Top Competitors

CompanyEmployeesRevenueTop technologies
Astex Pharmaceuticals Inc

Astex Pharmaceuticals Inc

150$51 M
Phasebio Pharmaceuticals

Phasebio Pharmaceuticals

60$10.9 M
Curza

Curza

99$20.8 M
Orphagen Pharmaceuticals Inc

Orphagen Pharmaceuticals Inc

86$19.4 M
Galileo Laboratories Inc

Galileo Laboratories Inc

30$5.9 M

What is AtheroGenics revenue?

AtheroGenics revenue is $13 M

How many employees does AtheroGenics have?

AtheroGenics has 70 employees

What are AtheroGenics’s primary industries?

AtheroGenics’s main industries are: Fitness & Dance Facilities, Hospitality

What are some additional names or alternative spellings that users use while searching for AtheroGenics?

AtheroGenics appears in search results as Atherogenics, Atherogenics Inc, HEROgenicsAthero Genics Inc...See More